Telemedicine-supported insulin optimisation in primary care.

Simple item page
dc.contributor.authorLarsen, Mark E
dc.contributor.authorTurner, Jane
dc.contributor.authorFarmer, Andrew
dc.contributor.authorNeil, Andrew
dc.contributor.authorTarassenko, Lionel
dc.date.accessioned2020-02-06T15:46:07Z
dc.date.available2020-02-06T15:46:07Z
dc.date.issued2010-11-25
dc.description.abstractWe investigated the feasibility of a mobile phone based system for patients with type 2 diabetes who had recently commenced insulin therapy but remained poorly controlled The system was evaluated in a feasibility study in a general practice setting with 23 patients over six months A total of 22 patients successfully completed the study and used the system for a mean of 217 days range 162 376 Blood glucose control improved as reflected by a mean decrease in HbA 1c of 0 66 P 0 05 with the mean insulin dose increasing by 17 units P 0 006 Blood glucose monitoring compliance was high with readings available for 6 2 days per week although use of the mobile phone decreased during the study On average the mobile phone diary was used for 3 5 days per week Insulin dose adjustments were made throughout the study by all patients but not as frequently as would be expected for the degree of hyperglycaemia observed
dc.identifier.urihttp://dx.doi.org/10.1258/jtt.2010.100103
dc.identifier.urihttps://lib.digitalsquare.io/xmlui/handle/123456789/674
dc.relation.uriJournal of telemedicine and telecare
dc.subjectDiabetes
dc.subjectChronic care
dc.subjectTreatment adherence
dc.subjectRemote client-to-provider consultations (Telemedicine)
dc.subjectDisease management
dc.subjectPrototype
dc.subjectLow adherence to treatments
dc.subjectAddressing individual beliefs and practices
dc.subjectFeasibility
dc.subjectPhysiologic Biosensors
dc.titleTelemedicine-supported insulin optimisation in primary care.en
dcterms.abstractWe investigated the feasibility of a mobile phone based system for patients with type 2 diabetes who had recently commenced insulin therapy but remained poorly controlled The system was evaluated in a feasibility study in a general practice setting with 23 patients over six months A total of 22 patients successfully completed the study and used the system for a mean of 217 days range 162 376 Blood glucose control improved as reflected by a mean decrease in HbA 1c of 0 66 P 0 05 with the mean insulin dose increasing by 17 units P 0 006 Blood glucose monitoring compliance was high with readings available for 6 2 days per week although use of the mobile phone decreased during the study On average the mobile phone diary was used for 3 5 days per week Insulin dose adjustments were made throughout the study by all patients but not as frequently as would be expected for the degree of hyperglycaemia observed
dcterms.contributorLarsen, Mark E
dcterms.contributorTurner, Jane
dcterms.contributorFarmer, Andrew
dcterms.contributorNeil, Andrew
dcterms.contributorTarassenko, Lionel
dcterms.identifierhttp://dx.doi.org/10.1258/jtt.2010.100103
dcterms.relationJournal of telemedicine and telecare
dcterms.subjectDiabetes
dcterms.subjectChronic care
dcterms.subjectTreatment adherence
dcterms.subjectRemote client-to-provider consultations (Telemedicine)
dcterms.subjectDisease management
dcterms.subjectPrototype
dcterms.subjectLow adherence to treatments
dcterms.subjectAddressing individual beliefs and practices
dcterms.subjectFeasibility
dcterms.subjectPhysiologic Biosensors
dcterms.titleTelemedicine-supported insulin optimisation in primary care.en
Files
Collections
mhealth Evidence